Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease

Conditions: Multiple Myeloma; Bone Diseases Interventions: Drug: Narlumosbart; Drug: Denosumab Sponsors: RenJi Hospital; Shanghai JMT-Bio Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06314698

Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

More News: Hospitals | Myeloma | Research | Xgeva